Letter to the Editor Regarding "Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study"

Chiara C Brück

doi:10.2147/NDT.S361484

Letter to the Editor Regarding "Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study"

Chiara C Brück

Public Health

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

13 Downloads (Pure)

Original language	English
Pages (from-to)	463-464
Number of pages	2
Journal	Neuropsychiatric Disease and Treatment
Volume	18
DOIs	https://doi.org/10.2147/NDT.S361484
Publication status	Published - 23 Feb 2022

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2147/NDT.S361484Licence: CC BY-NC

NDT-361484-letter-to-the-editor-regarding--ldquo-fluoxetine-may-enhanceFinal published version, 283 KBLicence: CC BY-NC

Cite this

@article{af7f251bda39470a812c3666ae2649dc,

title = "Letter to the Editor Regarding {"}Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study{"}",

author = "Br{\"u}ck, {Chiara C}",

note = "{\textcopyright} 2022 Br{\"u}ck. This work is published and licensed by Dove Medical Press Limited.",

year = "2022",

month = feb,

day = "23",

doi = "10.2147/NDT.S361484",

language = "English",

volume = "18",

pages = "463--464",

journal = "Neuropsychiatric Disease and Treatment",

issn = "1176-6328",

publisher = "Dove Medical Press Ltd.",

}

Letter to the Editor Regarding "Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study". / Brück, Chiara C.
In: Neuropsychiatric Disease and Treatment, Vol. 18, 23.02.2022, p. 463-464.

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

TY - JOUR

T1 - Letter to the Editor Regarding "Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study"

AU - Brück, Chiara C

PY - 2022/2/23

Y1 - 2022/2/23

UR - http://www.scopus.com/inward/record.url?scp=85125849565&partnerID=8YFLogxK

U2 - 10.2147/NDT.S361484

DO - 10.2147/NDT.S361484

M3 - Comment/Letter to the editor

C2 - 35250270

SN - 1176-6328

VL - 18

SP - 463

EP - 464

JO - Neuropsychiatric Disease and Treatment

JF - Neuropsychiatric Disease and Treatment

ER -

Letter to the Editor Regarding "Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study"

Bibliographical note

UN SDGs

Access to Document

Other files and links

Cite this